Literature DB >> 16751362

Biliary obstruction selectively expands and activates liver myeloid dendritic cells.

Joshua I Bleier1, Steven C Katz, Umer I Chaudhry, Venu G Pillarisetty, T Peter Kingham, Alaap B Shah, Jesse R Raab, Ronald P DeMatteo.   

Abstract

Obstructive jaundice is associated with immunologic derangements and hepatic inflammation and fibrosis. Because dendritic cells (DCs) play a major role in immune regulation, we hypothesized that the immunosuppression associated with jaundice may result from the functional impairment of liver DCs. We found that bile duct ligation (BDL) in mice expanded the myeloid subtype of liver DCs from 20 to 80% of total DCs and increased their absolute number by >15-fold. Liver myeloid DCs following BDL, but not sham laparotomy, had increased Ag uptake in vivo, high IL-6 secretion in response to LPS, and enhanced ability to activate T cells. The effects of BDL were specific to liver DCs, as spleen DCs were not affected. Expansion of liver myeloid DCs depended on Gr-1(+) cells, and we implicated monocyte chemotactic protein-1 as a potential mediator. Thus, obstructive jaundice selectively expands liver myeloid DCs that are highly functional and unlikely to be involved with impaired host immune responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16751362     DOI: 10.4049/jimmunol.176.12.7189

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  Myeloid Cells and Chronic Liver Disease: a Comprehensive Review.

Authors:  Min Lian; Carlo Selmi; M Eric Gershwin; Xiong Ma
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

Review 2.  Dietary and metabolic modulators of hepatic immunity.

Authors:  Antonella Carambia; Johannes Herkel
Journal:  Semin Immunopathol       Date:  2017-11-06       Impact factor: 9.623

3.  Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils.

Authors:  Lauren A Licata; Cang T Nguyen; Rachel A Burga; Vincent Falanga; N Joseph Espat; Alfred Ayala; Mitchell Thorn; Richard P Junghans; Steven C Katz
Journal:  J Leukoc Biol       Date:  2013-07-24       Impact factor: 4.962

4.  Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis.

Authors:  Steven C Katz; Kristin Ryan; Naseem Ahmed; George Plitas; Umer I Chaudhry; T Peter Kingham; Seema Naheed; Cang Nguyen; Ponnandai Somasundar; N Joseph Espat; Richard P Junghans; Ronald P Dematteo
Journal:  J Immunol       Date:  2011-06-22       Impact factor: 5.422

Review 5.  Inflammation and Cell Death During Cholestasis: The Evolving Role of Bile Acids.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  Gene Expr       Date:  2019-06-28

Review 6.  Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology.

Authors:  Claudia D Fuchs; Michael Trauner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-02-14       Impact factor: 73.082

7.  Contrasting responses of Kupffer cells and inflammatory mononuclear phagocytes to biliary obstruction in a mouse model of cholestatic liver injury.

Authors:  Caroline C Duwaerts; Stephan Gehring; Chao-Wen Cheng; Nico van Rooijen; Stephen H Gregory
Journal:  Liver Int       Date:  2012-12-13       Impact factor: 5.828

Review 8.  Dendritic cells and liver fibrosis.

Authors:  Adeeb H Rahman; Costica Aloman
Journal:  Biochim Biophys Acta       Date:  2013-01-09

9.  Regulatory T cells control the CD8 adaptive immune response at the time of ductal obstruction in experimental biliary atresia.

Authors:  Celine S Lages; Julia Simmons; Claire A Chougnet; Alexander G Miethke
Journal:  Hepatology       Date:  2012-06-06       Impact factor: 17.425

10.  Cholangiocyte secretion of chemokines in experimental biliary atresia.

Authors:  Mubeen Jafri; Bryan Donnelly; Alex Bondoc; Steven Allen; Greg Tiao
Journal:  J Pediatr Surg       Date:  2009-03       Impact factor: 2.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.